Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Does Race/Ethnicity Impact Umbilical Cord Blood Transplant Outcomes in a Contemporary Era?
Ballen, Karen K. , Wang, Tao , He, Naya, Hashmi, Shahrukh K. , Lehmann, Leslie , Rangarajan, Hemalatha G. , Saber, Wael , Wood, William A.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 685-686

10.1182/blood-2022-159152 Get It

Increased Tumor-Associated CD66b+ Myeloid-Derived Suppressor Cells in Waldenstrom Macroglobulinemia Inhibit T-Cell Immune Function
Bhardwaj, Vaishali , Jalali, Shahrzad , Tang, Xinyi , Mukherjee, Prithviraj , Kim, Hyo-Jin, Mudappathi, Rekha , Wenzl, Kerstin , Novak, Anne J. , Ansell, Stephen M. , Bhardwaj, Vaishali , Villasboas, José C. , Yang, Zhi-Zhang , Mondello, Patrizia , Wang, Junwen , Krull, Jordan E.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2904-2905

10.1182/blood-2022-166450 Get It

Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium
Day, Jonathan R , Lossos, Izidore S. , Friedberg, Jonathan W. , Flowers, Christopher R. , Larson, Melissa C. , Casulo, Carla , Wang, Yucai , Chihara, Dai , Kahl, Brad S. , Martin, Peter, Orellana‐Noia, Victor M. , Burack, Richard , Habermann, Thomas M. , Cerhan, James R. , Maurer, Matthew J. , Link, Brian K.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6642-6644

10.1182/blood-2022-157083 Get It

Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
Geramita, Emily , Bastacky, Melissa, Cohen, Jessica B, Shallis, Rory M. , Litzow, Mark R. , Im, Annie , Wang, Hong , Bastacky, Melissa L. , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6187-6188

10.1182/blood-2022-170647 Get It

TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799

10.1182/blood-2022-165859 Get It

Clinical Benefit Associated with Biomarker Changes Indicative of Disease Modification in Patients with Myelofibrosis Treated with the BET Inhibitor Pelabresib As Monotherapy or in Combination with Ruxolitinib
Kremyanskaya, Marina , Rampal, Raajit K. , Patriarca, Andrea, Zavidij, Oksana, Chang, Tzuu-Wang, Taverna, Pietro, Harrison, Claire , Scandura, Joseph Michael , Verstovšek, Srđan , Talpaz, Moshe , Vannucchi, Alessandro M. , Gupta, Vikas , Palandri, Francesca , Patriarca, Andrea , Bose, Prithviraj , Chen, Dong , Cui, Jike , Mascarenhas, John

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1523-1525

10.1182/blood-2022-159409 Get It

Targeted Nanotherapy of Hematologic Malignancies Using Gold Nanoframework-Based Delivery of a Novel NF-Kb Inhibitor
Zhang, Beilu, Tan, Ming , Wang, Jinping , Feinman, Rena , Liou, Hsiou‐Chi , Ouk, Samedy , Bariana, Manpreet , Sun, Jingyu , Cassella, Elena , Rateshwar, Janice , Wang, Weiwei , Siegel, David S. , Mondello, Patrizia , Wang, Hongjun , Zakrzewski, Johannes L.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6018-6019

10.1182/blood-2022-160324 Get It